Basal ganglia hypoactivity during grip force in drug naïve Parkinson's disease

Human Brain Mapping

Volumn 31, Issue 12, 2010, Pages 1928-1941

  Spraker, Matthew B ^a   Prodoehl, Janey ^b   Corcos, Daniel M ^a,b,c   Comella, Cynthia L ^c   Vaillancourt, David E ^a,b  

^a University of Illinois at Chicago   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

FMRI; Force; Parkinson's disease

Indexed keywords

ADULT; AGED; ARTICLE; BASAL GANGLION; BLOOD OXYGENATION; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLOBUS PALLIDUS; HUMAN; MOTOR PERFORMANCE; PARKINSON DISEASE; PRECISION GRIP; PREMOTOR CORTEX; PRIORITY JOURNAL; PROSPECTIVE STUDY; TASK PERFORMANCE; THALAMUS;

ADULT; AGED; BASAL GANGLIA; CASE-CONTROL STUDIES; CEREBELLUM; FEMALE; HAND STRENGTH; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE; PROSPECTIVE STUDIES;

EID: 78649600090     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.20987     Document Type: Article

References (34)

1. Blood AJ, Flaherty AW, Choi JK, Hochberg FH, Greve DN, Bonmassar G, Rosen BR, Jenkins BG (2004): Basal ganglia activity remains elevated after movement in focal hand dystonia. Ann Neurol 55: 744-748.
2. Bruck A, Aalto S, Nurmi E, Vahlberg T, Bergman J, Rinne JO (2006): Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: A two-year follow-up study. Mov Disord 21: 958-963.
3. Buhmann C, Glauche V, Sturenburg HJ, Oechsner M, Weiller C, Buchel C (2003): Pharmacologically modulated fMRI-cortical responsiveness to levodopa in drug-naive hemiparkinsonian patients. Brain 126 (Pt 2): 451-461.
4. Cools AR, Jaspers R, Schwarz M, Sontag KH, Vrijmoed-de Vries M, van den Bercken J (1984): Basal ganglia and switching motor programs. In: McKenzie JS, Kemm RE, Wilcock LN, editors. The Basal Ganglia Structure and Function. New York: Plenum Press, pp 513-544.
5. Dirnberger G, Frith CD, Jahanshahi M (2005): Executive dysfunction in Parkinson's disease is associated with altered pallidal-frontal processing. Neuroimage 25: 588-599.
6. Eckert T, Tang C, Eidelberg D (2007): Assessment of the progression of Parkinson's disease: A metabolic network approach. Lancet Neurol 6: 926-932.
7. Eidelberg D, Moeller JR, Kazumata K, Antonini A, Sterio D, Dhawan V, Spetsieris P, Alterman R, Kelly PJ, Dogali M, Fazzini E, Beric A (1997): Metabolic correlates of pallidal neuronal activity in Parkinson's disease. Brain 120 (Pt 8): 1315-1324.
8. Feigin A, Kaplitt MG, Tang C, Lin T, Mattis P, Dhawan V, During MJ, Eidelberg D (2007): Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease. Proc Natl Acad Sci USA 104: 19559-19564.
9. Fleminger S (1992): Control of simultaneous movements distinguishes depressive motor retardation from Parkinson's disease and neuroleptic parkinsonism. Brain 115 (Pt 5): 1459-1480.
10. Georgiou N, Bradshaw JL, Iansek R, Phillips JG, Mattingley JB, Bradshaw JA (1994): Reduction in external cues and movement sequencing in Parkinson's disease. J Neurol Neurosurg Psychiatry 57: 368-370.
11. Giladi N, Kao R, Fahn S (1997): Freezing phenomenon in patients with parkinsonian syndromes. Mov Disord 12: 302-305.
12. Grafton ST, Turner RS, Desmurget M, Bakay R, Delong M, Vitek J, Crutcher M (2006): Normalizing motor-related brain activity: Subthalamic nucleus stimulation in Parkinson disease. Neurology 66: 1192-1199.
13. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ (2001): What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study. Neurology 57 (10 Suppl. 3): S34-S38.
14. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992): Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184.
15. Jahanshahi M, Jenkins IH, Brown RG, Marsden CD, Passingham RE, Brooks DJ (1995): Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects. Brain 118 (Pt 4): 913-933.
16. Ma Y, Tang C, Spetsieris PG, Dhawan V, Eidelberg D (2007): Abnormal metabolic network activity in Parkinson's disease: Test-retest reproducibility. J Cereb Blood Flow Metab 27: 597-605.
17. Mayka MA, Corcos DM, Leurgans SE, Vaillancourt DE (2006): Three-dimensional locations and boundaries of motor and premotor cortices as defined by functional brain imaging: A meta-analysis. Neuroimage 31: 1453-1474.
18. Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, Torizuka T (2005): Microglial activation and dopamine terminal loss in early Parkinson's disease. Ann Neurol 57: 168-175.
19. Penn RD, Kroin JS, Reinkensmeyer A, Corcos DM (1998): Injection of GABA-agonist into globus pallidus in patient with Parkinson's disease. Lancet 351: 340-341.
20. Playford ED, Jenkins IH, Passingham RE, Nutt J, Frackowiak RS, Brooks DJ (1992): Impaired mesial frontal and putamen activation in Parkinson's disease: A positron emission tomography study. Ann Neurol 32: 151-161.
21. Prodoehl J, Yu H, Little DM, Abraham I, Vaillancourt DE (2008): Region of interest template for the human basal ganglia: Comparing EPI and standardized space approaches. Neuroimage 39: 956-965.
22. Rand MK, Stelmach GE (1999): Effects of increased stroke number on sequential arm movements in Parkinson's disease subjects. Parkinsonism Relat Disord 5: 27-35.
23. Rascol O, Sabatini U, Fabre N, Brefel C, Loubinoux I, Celsis P, Senard JM, Montastruc JL, Chollet F (1997): The ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic parkinsonian patients. Brain 120 (Pt 1): 103-110.
24. Sabatini U, Boulanouar K, Fabre N, Martin F, Carel C, Colonnese C, Bozzao L, Berry I, Montastruc JL, Chollet F et al. (2000): Cortical motor reorganization in akinetic patients with Parkinson's disease: A functional MRI study. Brain 123 (Pt 2): 394-403.
25. Samuel M, Ceballos-Baumann AO, Turjanski N, Boecker H, Gorospe A, Linazasoro G, Holmes AP, DeLong MR, Vitek JL, Thomas DG et al. (1997): Pallidotomy in Parkinson's disease increases supplementary motor area and prefrontal activation during performance of volitional movements an H2(15)O PET study. Brain 120 (Pt 8): 1301-1313.
26. Spraker MB, Corcos DM, Vaillancourt DE (2009): Cortical and subcortical mechanisms for precisely controlled force generation and force relaxation. Cereb Cortex 19: 2640-2650.
27. Stelmach GE, Worringham CJ, Strand EA (1987): The programming and execution of movement sequences in Parkinson's disease. Int J Neurosci 36: 55-65.
28. Thobois S, Jahanshahi M, Pinto S, Frackowiak R, Limousin-Dowsey P (2004): PET and SPECT functional imaging studies in Parkinsonian syndromes: From the lesion to its consequences. Neuroimage 23: 1-16.
29. Thulborn KR (1999): Visual feedback to stabilize head position for fMRI. Magn Reson Med 41: 1039-1043.
30. Vaillancourt DE, Spraker MB, Prodoehl J, Abraham I, Corcos DM, Zhou XJ, Comella CL, Little DM (2009): High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 72: 1378-1384.
31. Vaillancourt DE, Thulborn KR, Corcos DM (2003): Neural basis for the processes that underlie visually guided and internally guided force control in humans. J Neurophysiol 90: 3330-3340.
32. Weiss P, Stelmach GE, Hefter H (1997): Programming of a movement sequence in Parkinson's disease. Brain 120 (Pt 1): 91-102.
33. Wu T, Hallett M (2005): A functional MRI study of automatic movements in patients with Parkinson's disease. Brain 128 (Pt 10): 2250-2259.
34. Yu H, Sternad D, Corcos DM, Vaillancourt DE (2007): Role of hyperactive cerebellum and motor cortex in Parkinson's disease. Neuroimage 35: 222-233.